Drospirenone/ethinylestradiol/levomefolic acid
(Redirected from Beyaz (medication))
Combined oral contraceptive pill
| Drug Information | |||
|---|---|---|---|
| Image | |||
| Identifiers
CAS Number PubChem DrugBank ChemSpider ID UNII KEGG ChEBI ChEMBL IUPAC Name |
Chemical Data
C H N O Molecular Weight | ||
Drospirenone/ethinylestradiol/levomefolic acid is a combined oral contraceptive pill that contains three active ingredients: drospirenone, ethinylestradiol, and levomefolic acid. This combination is used primarily for birth control and to provide a supplemental source of folate.
Components[edit | edit source]
- Drospirenone: A synthetic progestin that mimics the activity of the natural hormone progesterone. It helps to prevent ovulation and causes changes in the cervical mucus and uterine lining, making it harder for sperm to reach the uterus and for a fertilized egg to attach to the uterus.
- Ethinylestradiol: A synthetic form of estrogen that works by inhibiting the release of gonadotropins from the pituitary gland, thereby preventing ovulation.
- Levomefolic acid: The active form of folic acid, a B vitamin that is important for the production and maintenance of new cells. It helps to reduce the risk of neural tube defects in a developing fetus if pregnancy occurs.
Mechanism of Action[edit | edit source]
The combination of drospirenone and ethinylestradiol works by preventing ovulation (the release of an egg from an ovary). It also causes changes in the cervical mucus and the lining of the uterus to prevent sperm from reaching the egg and to prevent a fertilized egg from attaching to the uterus. Levomefolic acid provides a supplemental source of folate to help reduce the risk of neural tube defects in case of pregnancy.
Uses[edit | edit source]
- Contraception: To prevent pregnancy.
- Acne treatment: Sometimes prescribed to treat moderate acne in women who also want to use an oral contraceptive.
- Premenstrual dysphoric disorder (PMDD): Can be used to treat symptoms of PMDD.
Side Effects[edit | edit source]
Common side effects may include:
Serious side effects may include:
Contraindications[edit | edit source]
- History of blood clots
- Stroke
- Heart disease
- Liver disease
- Breast cancer
Related Pages[edit | edit source]
 | This medical article is a stub. You can help WikiMD by expanding it. |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
